ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989